Hypoparathyroidism (chronic; post-surgical & autoimmune)
calcium-bone · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Deficient PTH causing hypocalcaemia with hyperphosphataemia and low/inappropriately normal PTH. Commonest cause is post-surgical (thyroid/parathyroid/neck surgery); also autoimmune (isolated or APS-1), DiGeorge/22q11, magnesium depletion (functional), activating CaSR mutation, radiation, infiltration. (Acute hypocalcaemic crisis/tetany is a separate entry.)
Red flags
- Carpopedal spasm, laryngospasm, seizures, prolonged QT / arrhythmia — acute emergency (IV calcium)
- Chvostek / Trousseau signs with symptomatic hypocalcaemia
- Nephrocalcinosis / rising creatinine from over-treatment and hypercalciuria
- Post-thyroidectomy falling calcium in first 24-72 h (hungry bone / transient hypoPTH)
Assessment
Differential diagnosis
- Vitamin D deficiency / malabsorption (PTH HIGH — secondary hyperparathyroidism)
- Pseudohypoparathyroidism (PTH resistance — high PTH, high phosphate)
- Severe hypomagnesaemia causing functional hypoPTH (correct Mg first)
- CKD-mineral bone disorder
- Hungry bone syndrome post-parathyroidectomy
- Acute pancreatitis, massive transfusion (citrate), tumour lysis
Investigations
- Corrected calcium (low) + PTH (low or inappropriately normal) + phosphate (high) — the triad
- Magnesium (low Mg causes and perpetuates hypocalcaemia — replace it)
- 25-OH vitamin D, U&E/eGFR, ALP
- 24-hour urinary calcium (risk of hypercalciuria/nephrocalcinosis on treatment)
- ECG (prolonged QT), renal tract imaging for nephrocalcinosis in long-standing disease
- Autoantibodies / genetic workup if non-surgical cause (APS-1, 22q11)
Management
- Correct magnesium first — hypocalcaemia will not resolve while hypomagnesaemic
- Acute symptomatic tetany/seizure/QT prolongation → IV calcium gluconate (see hypocalcaemic crisis entry)
- Chronic management: active vitamin D analogue (alfacalcidol/calcitriol) + oral calcium, because PTH absence impairs renal 1-alpha-hydroxylation
- Target calcium in LOW-normal range to minimise hypercalciuria and renal damage; avoid over-treatment
- Monitor calcium, phosphate, magnesium, renal function and 24-h urine calcium; add thiazide to reduce hypercalciuria if needed
- Keep calcium-phosphate product controlled (dietary phosphate restriction, phosphate binders if needed)
- Refer for PTH replacement (recombinant PTH) if poorly controlled on conventional therapy
Drugs & doses
Alfacalcidol 0.25-1 µg PO od OR calcitriol 0.25-1 µg PO od (titrate to low-normal calcium)
Calcium carbonate 500-1000 mg elemental calcium PO 2-3 times daily (with meals as binder, between meals for absorption)
Magnesium replacement if low: oral magnesium, or IV magnesium sulfate 2 g if severe/symptomatic [verify local]
Hydrochlorothiazide 12.5-25 mg PO od to reduce hypercalciuria (with low-sodium diet) [verify local]
Recombinant PTH (1-84) / palopegteriparatide SC — specialist use for refractory disease [verify local]
Disposition
Outpatient endocrine follow-up with regular calcium/renal monitoring. Admit for symptomatic hypocalcaemia, tetany, seizures or QT prolongation.
Complications & pitfalls
- Nephrocalcinosis, nephrolithiasis, CKD from chronic hypercalciuria
- Basal ganglia calcification, cataracts, extrapyramidal features
- Seizures, laryngospasm, cardiac arrhythmia
- Over-treatment hypercalcaemia
Exam pearls
- Always check and correct magnesium — low Mg both impairs PTH secretion and causes end-organ PTH resistance.
- Use ACTIVE vitamin D (alfacalcidol/calcitriol), not plain colecalciferol, because absent PTH impairs renal 1-alpha-hydroxylation.
- Aim for low-normal calcium: in hypoPTH there is no PTH to drive renal calcium reabsorption, so normal-high calcium causes heavy hypercalciuria and stones.
- Recombinant PTH is reserved for patients not controlled on calcium + active vitamin D.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.